Editorial
Published on 11 Jul 2022
Editorial: The Process Evaluation of Clinical Trials
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.950637
- 3,860 views
- 6 citations
- Frontiers in Medicine
- Regulatory Science
- Articles
Type at least 3 characters
435 articles
Original Research
Published on 22 Jun 2022
The Evaluation of Physiological Index Changes and Safety Work of Female Medical Staff With Different Medical Protection Standards in the Ward of COVID-19
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.906140
- 2,550 views
- 1 citation
Review
Published on 21 Jun 2022
A VOSviewer-Based Bibliometric Analysis of Prescription Refills
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.856420
- 7,379 views
- 26 citations
Original Research
Published on 16 Jun 2022
Characterization of Factors Predicting a Favorable Opinion of Research Applications Submitted for an Ethical Review Process
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.878786
- 1,657 views
Methods
Published on 15 Jun 2022
Process Evaluation of an Implementation Trial: Design, Rationale, and Early Lessons Learnt From an International Cluster Clinical Trial in Intracerebral Hemorrhage
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.813749
- 3,940 views
- 2 citations
Policy and Practice Reviews
Published on 15 Jun 2022
From COVID-19 Pandemic to Patient Safety: A New “Spring” for Telemedicine or a Boomerang Effect?
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.901788
- 6,194 views
- 23 citations
Original Research
Published on 14 Jun 2022
A Comparison of Post-marketing Measures Imposed by Regulatory Agencies to Confirm the Tissue-Agnostic Approach
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.893400
- 4,142 views
- 5 citations
Original Research
Published on 09 Jun 2022
Back to the Roots of Nursing: Qualitative Study on the Experience of Nurses in the Front Line During the COVID-19 Pandemic
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.903517
- 9,721 views
- 8 citations
Original Research
Published on 06 Jun 2022
Application of Internet of Medical/Health Things to Decentralized Clinical Trials: Development Status and Regulatory Considerations
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.903188
- 4,165 views
- 6 citations
Original Research
Published on 03 Jun 2022
Social Engagement in the Fight Against COVID-19 in the Urban and Peri-Urban Areas of Cotonou (Benin, Sub-saharan Africa): Acceptability of the Vaccination and Tracking Program
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.857890
- 4,567 views
- 5 citations
Opinion
Published on 17 May 2022
Existing Knowledge of Medication Error Must Be Better Translated Into Improved Patient Safety
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.870587
- 4,643 views
- 13 citations
Original Research
Published on 17 May 2022
Global Research Trends of Gender-Related Artificial Intelligence in Medicine Between 2001–2020: A Bibliometric Study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.868040
- 3,473 views
- 5 citations
Original Research
Published on 13 May 2022
METORY: Development of a Demand-Driven Blockchain-Based Dynamic Consent Platform Tailored for Clinical Trials
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.837197
- 2,888 views
- 14 citations
Perspective
Published on 13 May 2022
A Regulatory Risk-Based Approach to ATMP/CGT Development: Integrating Scientific Challenges With Current Regulatory Expectations
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.855100
- 16,042 views
- 17 citations
Policy and Practice Reviews
Published on 10 May 2022
20 Years of Legislation - How Australia Has Responded to the Challenge of Regulating Genetically Modified Organisms in the Clinic
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.883434
- 13,996 views
- 5 citations
Original Research
Published on 06 May 2022
Evaluation of Companion Diagnostics in Scientific Advice and Drug Marketing Authorization Applications by the European Medicines Agency
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.893028
- 7,038 views
- 4 citations